Tivozanib

Red

Brand Name(s):Fotivda

Indication:Renal cell carcinoma (advanced) and for adult patients who are VEGFR and mTOR pathway inhibitor-naïve following disease progression after one prior treatment with cytokine therapy for advanced RCC.

Rationale:1,2,3

Considered:Feb-18

Review Date:Mar-23

Comments: